Showing results (111-120 of 199) with videos related to
Sort By:
Pageof 20
Haematologica|June 13, 2015
Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: results of the randomized AZABACHE Spanish trialRamón García-Sanz, Albert Oriol, María J Moreno, et al.Journal of Geriatric Oncology|November 20, 2022
Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH studyJavier de la Rubia, Bernardo González, Alfonso J Cruz-Jentoft, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Genetic abnormalities and patterns of antigenic expression in multiple myelomaGema Mateo, Mariana Castellanos, Ana Rasillo, et al.The Lancet. Oncology|July 13, 2016
Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trialMaría-Victoria Mateos, Miguel-Teodoro Hernández, Pilar Giraldo, et al.The Oncologist|May 11, 2012
European perspective on multiple myeloma treatment strategies: update following recent congressesHeinz Ludwig, Hervé Avet-Loiseau, Joan Bladé, et al.Medicina Clinica|July 16, 2021
Recommendations for the diagnosis and treatment of patients with thrombotic thrombocytopenic purpuraMaría Eva Mingot Castellano, Cristina Pascual Izquierdo, Ataulfo González, et al.Blood|February 2, 2021
Redefining outcomes in immune TTP: an international working group consensus reportAdam Cuker, Spero R Cataland, Paul Coppo, et al.Transplantation and Cellular Therapy|March 11, 2025
Infectious Enterocolitis in Hematopoietic Cell Transplant with Post-Transplant CyclophosphamidePedro Chorão, André Airosa Pardal, Santiago de Cossio, et al.The New England Journal of Medicine|August 2, 2013
Lenalidomide plus dexamethasone for high-risk smoldering multiple myelomaMaría-Victoria Mateos, Miguel-Teodoro Hernández, Pilar Giraldo, et al.Transplantation and Cellular Therapy|September 13, 2023
Real-World Experience in Extracorporeal Photopheresis for Adults with Graft-versus-Host DiseasePedro Asensi Cantó, Jaime Sanz Caballer, Clara Sopeña Pell-Ilderton, et al.Pageof 20